Terran Biosciences

Terran Biosciences is a biotechnology and healthcare company founded in 2017 with a mission to transform the lives of patients with neurological and psychiatric illnesses. The company is dedicated to developing a broad portfolio of transformative therapeutics and technologies to address the unmet needs in this critical area of healthcare. Their slogan, "Transforming the lives of patients with neurological and psychiatric illnesses," encapsulates their commitment to making a significant impact in these fields. The recent Venture Round investment at 01 January 2022 signifies the confidence of investors in Terran Biosciences' potential. The investment was spearheaded by Catalytic Impact Foundation, Noetic Fund, PsyMed Ventures, and Victor Douce, demonstrating a diverse group of backers who recognize the value and potential of the company's initiatives. Terran Biosciences' headquarters is located in the United States, strategically positioning them within a prominent hub for biotechnology and healthcare innovation. Their focus on neurological and psychiatric diseases aligns with the increasing importance of addressing mental health and neurological disorders, presenting a substantial market opportunity. In summary, Terran Biosciences' innovative approach, recent investment, and strategic focus make them a compelling player in the biotechnology and healthcare space, with the potential to drive significant advancements in the treatment of neurological and psychiatric illnesses.